Stem (STEM)
(Delayed Data from NYSE)
$0.62 USD
+0.04 (6.03%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $0.62 0.00 (0.47%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Microbot Medical Inc. [STEM]
Reports for Purchase
Showing records 61 - 80 ( 84 total )
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY.
Provider: Roth Capital Partners, Inc.
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
Dosing of the 2nd Cohort of Phase I/II Study in SCI Begins, as Expected.
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
CIRM Grants Set to Provide Key Leverage for HuCNS-SC Programs
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
Appeal Works! Second $20 Million Grant Awarded from CIRM
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
Important SCI Headline Drives Excitement; Maintain Neutral
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
Overhang Removed; Downgrade to Neutral on Lack of Catalysts
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
2Q12 Results; Update from the SCI Study in September
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
IP Position Strengthened with Japan Patent Win
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
Cash the Check; STEM Gets Full $20 Million from CIRM
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
CIRM Grant Awarded for SCI; Expect $ Amount to be Meaningful
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
Nice Feather In Hat to Support Potential CIRM Grant
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Microbot Medical Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.